TRiNDS Team Spotlight: Ana Christensen, Director of Strategic Solutions

July 11, 2022

TRiNDS Team Spotlight: Ana Christensen, Director of Strategic Solutions

All of us at TRiNDS come to work every day committed to conducting the best quality rare disease and neuromuscular research. Today we’d like to highlight Ana Christensen, our Director of Strategic Solutions. We sat down with Ana to learn more about her and her work.

How and why did you come to work in clinical research and what has kept you in this field?  

Ana: I initially came to work in clinical research by accident. I didn’t know that clinical research was a career option after I finished my Master’s in Public Health – I thought I’d be working for a health department. What keeps me in clinical research is the ability to answer important questions that matter to health care providers, insurers, and families living with a diagnosis. I love that we can learn what a new therapy or treatment approach can change in the lives of people, and then use the data to drive policy and clinical care decisions.

Since you were last featured in the blog in 2020, you’ve been promoted to TRiNDS Director of Strategic Solutions. What does your typical day look like at TRiNDS now?

Ana: Some parts of my role are still the same – I still work directly with clients to manage their projects, and to engage with the community. I’ve been excited to join the TRiNDS Director team and have been learning a lot from our other Directors. Our Strategic Solutions have been very popular with our clients, so I’ve been working with our team to build more capacity for future clients – to ensure our service offerings are keeping up with demand, to grow our networks of subject matter experts, and to continue to strengthen relationships with key opinion leaders and advocacy groups. Whether I’m working on a project or building the team, I spend a fair amount of time in meetings and in building consensus.

What are you most excited about for the future of neuromuscular research? 

Ana: I’m most excited about the possibility of investigational drugs and therapies that could help a wider group of patients living with neuromuscular disorders. Whether it’s for patients who are non-ambulatory, adults, or young children – I think there’s a lot of room for the field to grow.

TRiNDS is a contract research organization (CRO) dedicated to conducting rare and neuromuscular disease research. We customize our services to each project to meet its unique needs. Contact TRiNDS today to learn more about how TRiNDS can help your project succeed.